Nile Therapeutics (NLTX) Posts Narrower than Expected Q4 Loss
Tweet
Share
E-mailGet Alerts NLTX Hot Sheet
Join SI Premium – FREE
Nile Therapeutics, Inc. (NASDAQ: NLTX) reported Q4 loss of $0.02, $0.02 better than the analyst estimate of ($0.04).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
- Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
